Related Experiment Video
Updated: May 13, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
T cell-based cancer immunotherapy: opportunities and challenges
Kaili Ma1, Yingxi Xu2, Hongcheng Cheng1
1National Key Laboratory of Immunity and Inflammation, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou 215123, China; Key Laboratory of Synthetic Biology Regulatory Element, Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou 215123, China.
T cell immunotherapy shows promise for cancer treatment, but effectiveness hinges on overcoming barriers in T cell activation, trafficking, and tumor cell killing. Understanding T cell differentiation is key to improving cancer immunity strategies.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- T cells are crucial for the cancer immunity cycle.
- Therapeutic success of T cell interventions depends on multiple factors throughout this cycle.
Purpose of the Study:
- To review advances in T cell immunotherapy.
- To identify barriers to T cell-mediated cancer immunity.
- To discuss factors influencing T cell differentiation and function.
Main Methods:
- Literature review and discussion of T cell immunotherapy.
- Analysis of T cell activation, trafficking, infiltration, and tumor cell killing.
- Exploration of factors influencing T cell differentiation, including TCR stimulation, costimulatory signals, cytokines, metabolic reprogramming, and mechanical forces.
Main Results:
- Key transcription factors and metabolic pathways dictate T cell differentiation and epigenetic programming.
- Barriers exist at multiple stages of the cancer immunity cycle, affecting T cell recognition, trafficking, and effector functions.
Conclusions:
- A deeper understanding of T cell fate determination is essential for developing novel strategies.
- Overcoming identified barriers can enhance the efficacy of T cell-based cancer immunotherapies.
More Related Videos
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Targeted Cancer Therapies
There are several types of targeted therapies against...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...